Days spent in acute care hospitals at the end of life of cancer patients in four Swiss cantons: a retrospective database study (SAKK 89/09)-Reference-Cited by-同舟云学术

Days spent in acute care hospitals at the end of life of cancer patients in four Swiss cantons: a retrospective database study (SAKK 89/09)

Published:2016-02-09 Issue:4 Volume:26 Page:e12453
ISSN:0961-5423
Container-title:European Journal of Cancer Care
language:en
Short-container-title:Eur J Cancer Care

Author:

Matter-Walstra K.W.¹²,Achermann R.³,Rapold R.³,Klingbiel D.²,Bordoni A.⁴,Dehler S.⁵,Konzelmann I.⁶,Mousavi M.⁷,Clough-Gorr K.M.⁸,Szucs T.¹³,Schwenkglenks M.¹,Pestalozzi B.C.⁹

Affiliation:

1. Institute of Pharmaceutical Medicine (ECPM); University of Basel; Basel Switzerland

2. Swiss Group for Clinical Cancer Research (SAKK); Bern Switzerland

3. (Formerly) Helsana Group; Dübendorf Switzerland

4. Cancer Registry Ticino; Instituto cantonale di patologia; Locarno Switzerland

5. Cancer Registry Zürich and Zug; University Hospital Zürich; Zürich Switzerland

6. Cancer Registry Valais; Observatoire valaisan de la santé; Sion Switzerland

7. Cancer Registry Basel; Gesundheitsdienste Projekte & Service; Basel Switzerland

8. Institute for Social and Preventative Medicine (ISPM); University of Bern; Bern Switzerland

9. Department Oncology; University Hospital Zürich; Zürich Switzerland

Funder

Swiss Cancer Research Foundation

EOL

Publisher

Wiley

Subject

Oncology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/ecc.12453/fullpdf

Reference37 articles.

1. Antibiotic use in adult outpatients in Switzerland in relation to regions, seasonality and point of care tests;Achermann;Clinical Microbiology and Infection,2011

2. The use of Complementary and Alternative Medicine by cancer patients;Adams;International Seminars in Surgical Oncology,2007

3. Safety and efficacy of the long-term adjuvant treatment of primary intermediate- to high-risk malignant melanoma (UICC/AJCC stage II and III) with a standardized fermented European mistletoe (Viscum album L.) extract. Results from a multicenter, comparative, epidemiological cohort study in Germany and Switzerland;Augustin;Arzneimittel-Forschung,2005

4. Mistletoe as complementary treatment in patients with advanced non-small-cell lung cancer treated with carboplatin-based combinations: a randomised phase II study;Bar-Sela;European Journal of Cancer,2013

5. Efficacy and safety of long-term complementary treatment with standardized European mistletoe extract (Viscum album L.) in addition to the conventional adjuvant oncologic therapy in patients with primary non-metastasized mammary carcinoma. Results of a multi-center, comparative, epidemiological cohort study in Germany and Switzerland;Bock;Arzneimittel-Forschung,2004

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An economic evaluation of an early palliative care intervention among patients with advanced cancer;Swiss Medical Weekly;2024-02-16

2. Clinical characteristics and therapeutic behavior of breast cancer patients using mistletoe therapy consulting a clinic offering integrative oncology: a registry data analysis;BMC Complementary Medicine and Therapies;2023-11-03

3. Days Spent at Home before Death from Cancer for Immigrants and Long-Term Residents in Ontario, Canada;Journal of Palliative Medicine;2021-04-01

4. Regional differences in healthcare costs at the end of life: an observational study using Swiss insurance claims data;International Journal of Public Health;2020-07

5. Use of selective serotonin reuptake inhibitors, other antidepressant medication, and risk of cataract: a case-control study based on Swiss claims data;European Journal of Clinical Pharmacology;2020-06-06